Skip to content

Clinical trials

Completed Phase 2 Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 2 Status: Completed Clear all

559 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200016
200114
200220
200312
200428
200530
200623
200732
200836
200926
201033
201126
201231
201321
201429
201529
201624
201717
201818
20199
20207
202110
20225
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed559

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center31
Mayo Clinic25
National Cancer Institute (NCI)25
Memorial Sloan Kettering Cancer Center19
M.D. Anderson Cancer Center15
University of Arkansas15
Celgene12
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins11
H. Lee Moffitt Cancer Center and Research Institute10
Amgen9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma559
Neoplasms, Plasma Cell136
Lymphoma, Non-Hodgkin103
Hodgkin Disease90
Leukemia, Lymphocytic, Chronic, B-Cell87
Precursor Cell Lymphoblastic Leukemia-Lymphoma77
Lymphoma73
Recurrence73
Leukemia, Myeloid, Acute70
Leukemia64

Trials

Showing 1 to 25 of 559. Each trial links to its page on Pharma Observatory.

459 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.